[Treatment of chronic obstructive pulmonary disease]

Area of Science:

• Pulmonology
• Epidemiology
• Pharmacology

Context:

• Chronic obstructive pulmonary disease (COPD) is a widespread respiratory condition with rising prevalence, morbidity, and mortality.
• Recent epidemiological studies highlight increasing trends in COPD cases and associated health burdens.

Purpose:

• To review current treatment strategies for COPD, including inhaled long-acting beta-2-agonists and glucocorticoids.
• To discuss the potential of emerging therapies, such as phosphodiesterase inhibitors, for managing COPD.

Summary:

• Long-acting inhaled beta-2-agonists have demonstrated significant utility in managing COPD.
• Inhaled glucocorticoids can reduce acute exacerbations and health status decline in specific COPD patient groups, especially when combined with long-acting beta-2-agonists.
• Advancements in understanding COPD pathogenesis are paving the way for novel treatments.

Impact:

• Improved management of COPD symptoms and exacerbations through established and emerging pharmacological interventions.
• Potential for disease-modifying treatments that could slow or halt the progression of COPD.
• Enhanced patient health status and reduced healthcare burden associated with COPD.